1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Oxford Nanopore Technologies Limited
  6. Summary
    ONT   GB00BP6S8Z30

OXFORD NANOPORE TECHNOLOGIES LIMITED

(ONT)
  Report
Delayed London Stock Exchange  -  05/20 11:35:14 am EDT
322.50 GBX   +9.32%
05/20OXFORD NANOPORE DELIVERS TECHNOLOGY UPDATE AT ANNUAL LONDON CALLING CONFERENCE : Bringing Together Years of Innovation to Showcase One Sensing Platform for All Biological Analyses
CI
04/03Certain Ordinary Shares of Oxford Nanopore Technologies Limited are subject to a Lock-Up Agreement Ending on 3-APR-2022.
CI
03/24Oxford Nanopore Announces Positive Evaluation of New Method for Rapid Drug-Resistant Tuberculosis DR-TB) Profiling
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
289.5(c) 294(c) 280(c) 295(c) 322.5(c) Last
1 691 467 1 636 430 872 371 1 379 619 2 366 342 Volume
+1.76% +1.55% -4.76% +5.36% +9.32% Change
More quotes
Estimated financial data (e)
Sales 2021 127 M 159 M 159 M
Net income 2021 -106 M -132 M -132 M
Net cash position 2021 538 M 670 M 670 M
P/E ratio 2021 -19,1x
Yield 2021 -
Sales 2022 158 M 197 M 197 M
Net income 2022 -114 M -142 M -142 M
Net cash position 2022 449 M 560 M 560 M
P/E ratio 2022 -23,0x
Yield 2022 -
Capitalization 2 654 M 3 308 M 3 308 M
EV / Sales 2021 16,6x
EV / Sales 2022 13,9x
Nbr of Employees 803
Free-Float 53,2%
More Financials
Company
Oxford Nanopore Technologies PLC is a United Kingdom-based company. The Company develops sensing technology that uses nanopores - nano-scale holes embedded in electronics, to perform molecular analyses. Its products sequence deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its product includes a sensing platform, which is used for the analysis of various types of molecules, such as proteins. The Company's... 
More about the company
All news about OXFORD NANOPORE TECHNOLOGIES LIMITED
05/20OXFORD NANOPORE DELIVERS TECHNOLOGY : Bringing Together Years of Innovation to Showcase O..
CI
04/03Certain Ordinary Shares of Oxford Nanopore Technologies Limited are subject to a Lock-U..
CI
03/24Oxford Nanopore Announces Positive Evaluation of New Method for Rapid Drug-Resistant Tu..
CI
03/23Oxford Nanopore Technologies Limited Announces Short Fragment Mode to Integrated into t..
CI
03/22Oxford Nanopore Technologies Widens FY21 Loss Amid Payment Charge, IPO Costs
MT
03/22Earnings Flash (ONT.L) OXFORD NANOPORE TECHNOLOGIES Reports FY21 EPS GBX23.00
MT
03/22Earnings Flash (ONT.L) OXFORD NANOPORE TECHNOLOGIES Reports FY21 Revenue GBP133.7M
MT
03/22Earnings Flash (ONT.L) OXFORD NANOPORE TECHNOLOGIES Reports FY21 Loss GBX-23.00
MT
03/22Oxford Nanopore Technologies Limited Reports Earnings Results for the Full Year Ended D..
CI
03/22Oxford Nanopore Technologies Limited Provides Group Revenue Guidance for the Full Year ..
CI
03/20OXFORD NANOPORE TECHNOLOGIES LIMITED : ONT) added to S&P Global BMI Index
CI
03/11Oracle's Fourth-Quarter Earnings Outlook Beats Guidance, Revenue Views Mixed as Cloud B..
MT
03/10Oracle Reports Lower 3Q Profit, Higher Revenue
DJ
03/08Researchers Use Oxford Nanopore Technology to Develop A Single Test Method to Character..
CI
01/24Oxford Nanopore Technologies Limited Appoint Wendy Becker as Senior Independent Directo..
CI
More news
News in other languages on OXFORD NANOPORE TECHNOLOGIES LIMITED
05/20OXFORD NANOPORE PRÉSENTE UNE MISE À : Rassembler des années d'innovation pour présenter u..
03/24Oxford Nanopore annonce l'évaluation positive d'une nouvelle méthode pour le profilage ..
03/23Oxford Nanopore Technologies Limited annonce l'intégration du mode " Short Fragment " d..
03/22Oxford Nanopore Technologies accroît sa perte pour l'exercice 21, en raison de frais de..
03/22Earnings Flash (ONT.L) OXFORD NANOPORE TECHNOLOGIES annonce un chiffre d'affaires de 13..
More news
Analyst Recommendations on OXFORD NANOPORE TECHNOLOGIES LIMITED
More recommendations
Chart OXFORD NANOPORE TECHNOLOGIES LIMITED
Duration : Period :
Oxford Nanopore Technologies Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OXFORD NANOPORE TECHNOLOGIES LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 322,50 GBX
Average target price 629,63 GBX
Spread / Average Target 95,2%
EPS Revisions
Managers and Directors
Gordon Sanghera Chief Executive Officer & Director
Tim Cowper Chief Financial Officer & Director
Peter Vance Allen Non-Executive Chairman
John Milton Chief Scientific Officer
Clive G. Brown Chief Technology Officer & Director
Sector and Competitors